　曩に高原教授は，第52回日本耳鼻咽喉科学会総会の宿題報告及び昭和26年4月21日登刊の日本医事新報（第1408号）誌上に於て，「耳管疾患の成因と治療」に就ての報告をされたが，其の中の耳管坐藥に就て，諸処より多数御問合せがあり，又度々坐藥譲渡の御飯頼等があつて多数の方々の御追試を頂いている事を知り，我々は非常に悦ばしく思つている次第である。此等御問合せの文面より，坐藥の製法及び使用法が可成り困難であるかの如き印象を持つて居られる樣に推察される処もあるので，茲に私達の今迄の経験を述べて，諸賢の御参考に供したいと思う．

TSUKAMOTO and associates report some fa-vorable results on treatment of tubotympanitis with newly devised suppository medication which is inserted into the auditory tube. This mode of therapy was originally suggested by Professor Takahara. The suppository is composed of a base which is carbowax compound whose molecular weight is 4,000 and addition of other ingredients such as 1 per cent ammonium chloride, 2 per ce-nt protargol, 0.01 per cent adrenalin chloride, 0.5 per cent ephedrine chloride, 1 per cent dionine, iodine and potassium iodine respectively and prop-ortionately to 0.0002g. and 0.02g. per gram of the substance, and, penicillin 1,000 u. to a gram. That the method is successful has been evidenced by freer passage of air into the auditory tube when tested with insufflation. Further study is being made for improvement of the agent.